Evidence map

TrialEuropean journal of clinical pharmacology1994

Metabolic effects of long-term angiotensin-converting enzyme inhibition with fosinopril in patients with essential hypertension: relationship to angiotensin-converting enzyme inhibition.

R Reneland et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 7957538